Cargando…
Prevalence of DNA repair gene mutations in localized prostate cancer according to clinical and pathologic features: Association of Gleason score and tumor stage
BACKGROUND: DNA repair gene mutations are present in 8–10% of localized prostate cancers. It is unknown if this is influenced by clinicopathologic factors. METHODS: We interrogated localized prostate adenocarcinomas with tumor DNA sequencing from the TCGA validated (n=333) and Nature Genetics (n=377...
Autores principales: | Marshall, Catherine Handy, Fu, Wei, Wang, Hao, Baras, Alexander S., Lotan, Tamara L., Antonarakis, Emmanuel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372344/ https://www.ncbi.nlm.nih.gov/pubmed/30171229 http://dx.doi.org/10.1038/s41391-018-0086-1 |
Ejemplares similares
-
Prostate-Specific Antigen Density and Gleason Score Predict Adverse Pathologic Features in Patients with Clinically Localized Prostate Cancer
por: Nowroozi, Mohammad Reza, et al.
Publicado: (2016) -
Multimodal Radiomic Features for the Predicting Gleason Score of Prostate Cancer
por: Chaddad, Ahmad, et al.
Publicado: (2018) -
AB177. Clinical and pathological research of prostate cancer with Gleason score 10
por: Yan, Bin, et al.
Publicado: (2016) -
Gleason score stratification according to age at diagnosis in 1028 men
por: Pepe, Pietro, et al.
Publicado: (2016) -
Recent decline in prostate cancer incidence in the United States, by age, stage, and Gleason score
por: Herget, Kimberly A., et al.
Publicado: (2015)